Thomas Chatzikonstantinou

9PUBLICATIONS
122CO-AUTHORS
Haematological tumoursRespiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)Cardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 19, 2025
Clinical and transcriptomic characterization of patients with chronic lymphocytic leukemia harboring t(14;19): an ERIC study.

Andrea Visentin, Enrico Gaffo, Moritz Fürstenau

|Aug 25, 2025
Assessing an eHealth Intervention on Quality of Life in Patients With Chronic Lymphocytic Leukemia and Myelodysplastic Syndromes: The MyPal Randomized Controlled Trial.

Thomas Chatzikonstantinou, Maria Vasilopoulou, Dimitrios Kyrou

|Jun 30, 2025
Disease-specific U1 spliceosomal RNA mutations in mature B-cell neoplasms.

Ferran Nadeu, Shimin Shuai, Guillem Clot

|Jun 24, 2025
Resistance to targeted therapies in chronic lymphocytic leukemia: Current status and perspectives for clinical and diagnostic practice.

Piers Blombery, Thomas Chatzikonstantinou, Marina Gerousi

|May 16, 2024
ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-2024 update.

Jitka Malcikova, Sarka Pavlova, Panagiotis Baliakas

|Sep 29, 2023
The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL.

Andrea Visentin, Thomas Chatzikonstantinou, Lydia Scarfò

Pageof 2

Frequent Collaborators

9 joint publications

Paolo Ghia

6 joint publications

Kostas Stamatopoulos

5 joint publications

Richard Rosenquist

4 joint publications

Livio Trentin